Median LCS (internal name) / eyonis LCS (trade name) (1.0)
K-Number: K251474 · 2026-02-06
ApplicantMedian Technologies
Decision Date2026-02-06
Product CodeQDQ
Advisory CommitteeRA
DecisionSubstantially Equivalent
Device Summary
Median LCS (internal name) / eyonis LCS (trade name) (1.0) is a medical device manufactured by Median Technologies. It received FDA 510(k) clearance on 2026-02-06 under approval number K251474. The device is classified under product code QDQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Median LCS (internal name) / eyonis LCS (trade name) (1.0)?
Median LCS (internal name) / eyonis LCS (trade name) (1.0) is a medical device that received FDA 510(k) clearance on 2026-02-06. It is manufactured by Median Technologies. The 510(k) number is K251474.
When was Median LCS (internal name) / eyonis LCS (trade name) (1.0) approved by the FDA?
Median LCS (internal name) / eyonis LCS (trade name) (1.0) received FDA 510(k) clearance on 2026-02-06, under approval number K251474.
What company makes Median LCS (internal name) / eyonis LCS (trade name) (1.0)?
Median LCS (internal name) / eyonis LCS (trade name) (1.0) is manufactured by Median Technologies.
What is the FDA product code for Median LCS (internal name) / eyonis LCS (trade name) (1.0)?
The FDA product code for Median LCS (internal name) / eyonis LCS (trade name) (1.0) is QDQ.
Related Clinical Trials
Related Devices (Code: QDQ)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.